Vittal Vasista, Chief Financial Officer at REGENXBIO Inc. (RGNX), sold 2,400 shares at $30.24 ($73K) on 2022-08-30, disclosed to the SEC on 2022-08-31.
Open-market sale of $73k RGNX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RGNX | SELL | 2022-07-15 | $274K | — | Filing → |
| RGNX | SELL | 2021-01-20 | $13K | — | Filing → |
| RGNX | SELL | 2021-01-14 | $1.3M | — | Filing → |